Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bryan Burnette

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Pharmacology|January 13, 2018
Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength ScoresJonathan H Soslow, Larry W Markham, W Bryan Burnette, et al.
Neuromuscular Disorders : NMD|April 16, 2020
Beyond ambulation: Measuring physical activity in youth with Duchenne muscular dystrophyMary Killian, Maciej S Buchowski, Thomas Donnelly, et al.
Pediatric Cardiology|July 30, 2014
Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imagingJonathan H Soslow, Bruce M Damon, Benjamin R Saville, et al.
Journal of Cardiac Failure|February 15, 2019
The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Duchenne Muscular Dystrophy CardiomyopathyJonathan H Soslow, Meng Xu, James C Slaughter, et al.
Muscle & Nerve|December 24, 2024
Physical Activity Correlates With Skeletal Muscle MRI Findings in Individuals With Duchenne Muscular DystrophyJaclyn Tamaroff, Nicholas Joy, Bruce Damon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2014
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic MelanomaDouglas B Johnson, Vita Saranga-Perry, Patrick J M Lavin, et al.
Neurology. Clinical Practice|October 14, 2024
Spinal Muscular Atrophy Update in Best Practices: Recommendations for Treatment ConsiderationsMary K Schroth, Jennifer Deans, Diana X Bharucha Goebel, et al.
Pediatric Neurology|December 16, 2025
Six-Minute Activity-95<sup>th</sup> Centile, a Novel Wearable-Derived Clinical Outcome Assessment for Duchenne Muscular DystrophyNicholas Joy, Jonathan Soslow, W Bryan Burnette, et al.
Journal of Neuromuscular Diseases|June 14, 2021
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD TrialRichard S Finkel, Craig M McDonald, H Lee Sweeney, et al.
Contemporary Clinical Trials Communications|August 11, 2018
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!Amy Bartlett, Stephen J Kolb, Allison Kingsley, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|January 13, 2018
Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength ScoresJonathan H Soslow, Larry W Markham, W Bryan Burnette, et al.
Neuromuscular Disorders : NMD|April 16, 2020
Beyond ambulation: Measuring physical activity in youth with Duchenne muscular dystrophyMary Killian, Maciej S Buchowski, Thomas Donnelly, et al.
Pediatric Cardiology|July 30, 2014
Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imagingJonathan H Soslow, Bruce M Damon, Benjamin R Saville, et al.
Journal of Cardiac Failure|February 15, 2019
The Role of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Duchenne Muscular Dystrophy CardiomyopathyJonathan H Soslow, Meng Xu, James C Slaughter, et al.
Muscle & Nerve|December 24, 2024
Physical Activity Correlates With Skeletal Muscle MRI Findings in Individuals With Duchenne Muscular DystrophyJaclyn Tamaroff, Nicholas Joy, Bruce Damon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2014
Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic MelanomaDouglas B Johnson, Vita Saranga-Perry, Patrick J M Lavin, et al.
Neurology. Clinical Practice|October 14, 2024
Spinal Muscular Atrophy Update in Best Practices: Recommendations for Treatment ConsiderationsMary K Schroth, Jennifer Deans, Diana X Bharucha Goebel, et al.
Pediatric Neurology|December 16, 2025
Six-Minute Activity-95<sup>th</sup> Centile, a Novel Wearable-Derived Clinical Outcome Assessment for Duchenne Muscular DystrophyNicholas Joy, Jonathan Soslow, W Bryan Burnette, et al.
Journal of Neuromuscular Diseases|June 14, 2021
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD TrialRichard S Finkel, Craig M McDonald, H Lee Sweeney, et al.
Contemporary Clinical Trials Communications|August 11, 2018
Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!Amy Bartlett, Stephen J Kolb, Allison Kingsley, et al.
Pageof 3